Antibiotice Financials
| ATB Stock | 2.70 0.02 0.75% |
Antibiotice |
Understanding current and past Antibiotice Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Antibiotice's financial statements are interrelated, with each one affecting the others. For example, an increase in Antibiotice's assets may result in an increase in income on the income statement.
| Foreign Associate | USA |
| Instrument | Romania Stock View All |
| Exchange | Bucharest Stock Exchange |
| ISIN | ROATBIACNOR9 |
| Benchmark | Dow Jones Industrial |
Antibiotice Ia Systematic Risk
Antibiotice's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Antibiotice volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Antibiotice Ia correlated with the market. If Beta is less than 0 Antibiotice generally moves in the opposite direction as compared to the market. If Antibiotice Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Antibiotice Ia is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Antibiotice is generally in the same direction as the market. If Beta > 1 Antibiotice moves generally in the same direction as, but more than the movement of the benchmark.
Antibiotice December 11, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Antibiotice help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Antibiotice Ia. We use our internally-developed statistical techniques to arrive at the intrinsic value of Antibiotice Ia based on widely used predictive technical indicators. In general, we focus on analyzing Antibiotice Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Antibiotice's daily price indicators and compare them against related drivers.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 21.59 | |||
| Value At Risk | (3.02) | |||
| Potential Upside | 4.5 |
Other Information on Investing in Antibiotice Stock
Antibiotice financial ratios help investors to determine whether Antibiotice Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Antibiotice with respect to the benefits of owning Antibiotice security.